Gene Therapy & RNA Therapeutics are redefining the future of disease treatment by targeting conditions at their genetic root. Gene therapy introduces functional genes into patients' cells to correct genetic mutations, using viral or non-viral vectors to deliver therapeutic DNA. Simultaneously, RNA-based drugs—such as siRNA, mRNA, and antisense oligonucleotides—are being used to silence, replace, or modulate gene expression with high specificity. Recent advances include mRNA vaccines and gene-editing platforms like CRISPR for correcting single-gene disorders. Gene Therapy & RNA Therapeutics are proving effective against cancer, rare genetic diseases, and neurodegenerative disorders. As delivery mechanisms and regulatory frameworks evolve, these molecular approaches are becoming more accessible and personalized, with potential to revolutionize preventive, curative, and precision medicine.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico